RhumbLine Advisers’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.4M Buy
807,161
+21,199
+3% +$967K 0.03% 485
2025
Q4
$34.8M Sell
785,962
-16,348
-2% -$704K 0.03% 492
2025
Q3
$33.9M Sell
802,310
-19,336
-2% -$780K 0.03% 507
2025
Q2
$30.1M Buy
821,646
+24,177
+3% +$898K 0.03% 538
2025
Q1
$30.4M Buy
797,469
+20,710
+3% +$770K 0.03% 507
2024
Q4
$29.4M Buy
776,759
+42,454
+6% +$1.7M 0.03% 515
2024
Q3
$29.9M Buy
734,305
+8,835
+1% +$334K 0.03% 519
2024
Q2
$24.8M Sell
725,470
-312
-0% -$9.83K 0.02% 564
2024
Q1
$23M Sell
725,782
-28,966
-4% -$881K 0.02% 632
2023
Q4
$23.1M Sell
754,748
-14,465
-2% -$464K 0.02% 594
2023
Q3
$25.5M Buy
769,213
+8,341
+1% +$266K 0.03% 504
2023
Q2
$23.4M Buy
760,872
+22,960
+3% +$663K 0.03% 571
2023
Q1
$20.2M Sell
737,912
-14,635
-2% -$407K 0.03% 600
2022
Q4
$21M Buy
752,547
+12,367
+2% +$373K 0.03% 562
2022
Q3
$21.8M Buy
740,180
+10,431
+1% +$327K 0.03% 494
2022
Q2
$20.6M Buy
729,749
+63,817
+10% +$1.82M 0.03% 517
2022
Q1
$20.8M Sell
665,932
-11,827
-2% -$349K 0.03% 565
2021
Q4
$20.1M Buy
677,759
+17,102
+3% +$499K 0.02% 622
2021
Q3
$19.8M Sell
660,657
-10,101
-2% -$348K 0.03% 596
2021
Q2
$24.3M Sell
670,758
-1,665
-0.2% -$61.8K 0.03% 511
2021
Q1
$24.6M Buy
672,423
+10,715
+2% +$394K 0.03% 493
2020
Q4
$24M Buy
661,708
+24,515
+4% +$831K 0.03% 473
2020
Q3
$19.1M Sell
637,193
-37,976
-6% -$1.19M 0.03% 491
2020
Q2
$20.1M Buy
675,169
+5,802
+0.9% +$172K 0.03% 449
2020
Q1
$17.8M Buy
669,367
+56,083
+9% +$2.13M 0.04% 424
2019
Q4
$26M Buy
613,284
+2,649
+0.4% +$112K 0.04% 386
2019
Q3
$25.5M Sell
610,635
-14,971
-2% -$583K 0.05% 369
2019
Q2
$23M Buy
625,606
+67,548
+12% +$2.46M 0.04% 403
2019
Q1
$21.3M Sell
558,058
-44,467
-7% -$1.65M 0.04% 415
2018
Q4
$21.2M Buy
602,525
+238,893
+66% +$8.28M 0.05% 391
2018
Q3
$11.9M Sell
363,632
-10,054
-3% -$320K 0.02% 613
2018
Q2
$11.6M Sell
373,686
-4,499
-1% -$129K 0.02% 616
2018
Q1
$10.2M Sell
378,185
-44,103
-10% -$1.18M 0.02% 658
2017
Q4
$11.6M Sell
422,288
-21,511
-5% -$621K 0.02% 621
2017
Q3
$14.2M Buy
443,799
+12,163
+3% +$390K 0.03% 538
2017
Q2
$14.3M Sell
431,636
-15,523
-3% -$514K 0.03% 516
2017
Q1
$14.8M Buy
447,159
+33,585
+8% +$1.08M 0.03% 506
2016
Q4
$12.9M Buy
413,574
+46,056
+13% +$1.42M 0.03% 528
2016
Q3
$13M Buy
367,518
+57,605
+19% +$2.05M 0.04% 474
2016
Q2
$10.5M Buy
309,913
+19,838
+7% +$662K 0.03% 523
2016
Q1
$10.2M Buy
290,075
+12,170
+4% +$399K 0.03% 531
2015
Q4
$9.72M Buy
277,905
+10,955
+4% +$378K 0.03% 531
2015
Q3
$9.38M Buy
266,950
+22,944
+9% +$806K 0.03% 525
2015
Q2
$8.38M Buy
244,006
+41,628
+21% +$1.53M 0.03% 593
2015
Q1
$8.21M Buy
202,378
+32,080
+19% +$1.33M 0.02% 603
2014
Q4
$6.65M Sell
170,298
-85
-0% -$3.22K 0.02% 655
2014
Q3
$5.83M Buy
170,383
+1,467
+0.9% +$54K 0.02% 701
2014
Q2
$6.23M Sell
168,916
-24,595
-13% -$878K 0.02% 694
2014
Q1
$6.49M Sell
193,511
-4,250
-2% -$135K 0.02% 689
2013
Q4
$5.89M Sell
197,761
-7,792
-4% -$247K 0.02% 732
2013
Q3
$6.14M Sell
205,553
-24,557
-11% -$747K 0.02% 708
2013
Q2
$7.14M Buy
+230,110
New +$7.56M 0.02% 613

Other funds holding OHI

RhumbLine Advisers's OHI Position: Q1 2026 in Review

RhumbLine Advisers increased its Omega Healthcare (OHI) stake by 2.7% in Q1 2026, buying an estimated $967K and bringing the position to 807,161 shares worth $35.4M. The position accounts for 0.03% of the portfolio, ranked #485.

RhumbLine Advisers first reported a position in OHI in Q2 2013 and has held it in 52 quarters since. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • RhumbLine Advisers held 807,161 shares of Omega Healthcare worth $35.4M as of Q1 2026.
  • RhumbLine Advisers bought 21,199 Omega Healthcare shares in Q1 2026, an estimated $967K.
  • Omega Healthcare made up 0.03% of RhumbLine Advisers's portfolio in Q1 2026, its #485 holding.
  • RhumbLine Advisers first reported a position in Omega Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.